OptimiTAR – Manejo de las resistencias en la optimización del TAR (segunda edición)

Jose Luis Blanco is a consultant at the HIV / AIDS Unit and Infectious Disease Service, Associate Professor University of Barcelona since 2015 and Professor del Master of AIDS University of Barcelona since 2002. He is Consultant in Charge of the Research in HIV Resistance and Rescue Therapies, Sexually Transmission Diseases Unit and Program of Anal Canal Prevention Program and he  is author of more than 100 scientific articles and the principal investigator of national and international projects in the field of HIV infection and related infections.

Arkaitz Imaz received his MD from University of Navarra in 2002 and completed his Internal Medicine training at Vall d’Hebron Hospital (Barcelona). He obtained his PhD from the Autonomous University of Barcelona in 2012.

In 2010 he joined the Department of Infectious Diseases of the Bellvitge University Hospital where he works as a physician in the HIV and STI Unit.

He is involved in clinical research in the field of HIV and antiretroviral therapy, participating in multiple research projects and clinical trials. He also acts as reviewer in several scientific journals and has participated in clinical guidelines on antiretroviral therapy, drug resistance and HIV-associated diseases.

Josep M Llibre, MD, PhD, received his MD in the Universitat de Barcelona, and obtained his specialty in Internal Medicine and his PhD in the Universitat Autònoma de Barcelona. He is a member of the panel of Antiretroviral treatment guidelines at the GeSIDA group (AIDS group of the SEIMC Spanish society), and an expert advisor of the Catalan Health Institute (ICS) on antiretroviral treatment and hepatitis C (PADEICS). He started caring for patients with HIV/AIDS at the beginning of the epidemic in Spain in 1987. His main areas of interest in HIV Medicine include the clinical implications of HIV-1 resistance, the analysis of safety and efficacy in HIV-1 antiretroviral treatment clinical trials (both in naïve and pre-treated patients), with a special interest in drug efficacy and pharmacoeconomics, and hepatitis C co-infection. He has published widely in journals and book chapters, as well as HIV/AIDS medical webs, on clinical aspects of HIV-1 treatment and care, HIV-1 resistance, clinical reviews, positioning papers, treatment intensification and simplification strategies, and participated in many pivotal clinical trials. He has also published in basic science research journals. He collaborates as an editor and/or peer-reviewing with many top international medical journals. He is involved in HIV Medical Educational training in Spain and other European, as well as Asian Countries.